Brandes Investment Partners LP Sells 822,769 Shares of Phibro Animal Health Co. (NASDAQ:PAHC)

Brandes Investment Partners LP lessened its position in shares of Phibro Animal Health Co. (NASDAQ:PAHC) by 55.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 661,970 shares of the company’s stock after selling 822,769 shares during the quarter. Brandes Investment Partners LP owned about 1.63% of Phibro Animal Health worth $13,901,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the company. Amundi grew its holdings in Phibro Animal Health by 185.5% during the 4th quarter. Amundi now owns 9,855 shares of the company’s stock valued at $212,000 after buying an additional 6,403 shares in the last quarter. Raymond James Financial Inc. purchased a new position in shares of Phibro Animal Health in the 4th quarter worth approximately $1,103,000. Charles Schwab Investment Management Inc. boosted its holdings in shares of Phibro Animal Health by 8.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 290,656 shares of the company’s stock worth $6,104,000 after purchasing an additional 22,263 shares during the period. Wakefield Asset Management LLLP purchased a new position in shares of Phibro Animal Health in the 4th quarter worth approximately $1,020,000. Finally, Los Angeles Capital Management LLC boosted its holdings in shares of Phibro Animal Health by 2.1% in the 4th quarter. Los Angeles Capital Management LLC now owns 24,042 shares of the company’s stock worth $505,000 after purchasing an additional 503 shares during the period. Hedge funds and other institutional investors own 99.34% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on PAHC shares. StockNews.com upgraded Phibro Animal Health from a “hold” rating to a “buy” rating in a report on Saturday. Morgan Stanley lifted their target price on Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a report on Tuesday, December 17th. Finally, Barclays boosted their price objective on Phibro Animal Health from $20.00 to $22.00 and gave the company an “underweight” rating in a report on Monday, February 10th. Two analysts have rated the stock with a sell rating, two have assigned a hold rating and one has assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $21.00.

Phibro Animal Health Price Performance

PAHC opened at $21.25 on Friday. The business has a fifty day moving average of $22.57 and a 200 day moving average of $22.57. Phibro Animal Health Co. has a 52-week low of $12.05 and a 52-week high of $26.55. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99. The stock has a market cap of $860.69 million, a P/E ratio of 44.27, a PEG ratio of 0.45 and a beta of 0.58.

Phibro Animal Health (NASDAQ:PAHC) last issued its earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, beating analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. As a group, sell-side analysts anticipate that Phibro Animal Health Co. will post 1.95 EPS for the current year.

Phibro Animal Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Wednesday, March 5th will be given a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 2.26%. The ex-dividend date of this dividend is Wednesday, March 5th. Phibro Animal Health’s payout ratio is 100.00%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.